09/24/2024
https://www.congress.gov...
"Already, FDA's inconsistent approval process has dampened investment."
"I don't think our country's had much of an innovation or growth strategy for the last decade-plus."
"It is long overdue. And I appreciate your interest in both competitiveness and innovation."
"the rate of change that we'd seen across the 16 metrics that Dr. Atkinson will describe later."